Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea

Association between Angiotensin-Converting Enzyme Inhibitors and Lung Cancer—A Nationwide, Population-Based, Propensity Score-Matched Cohort Study

(2020) Shih-Yi Lin et al.   Cancers

Intriguing relationship between antihypertensive therapy and cancer

(2019) Marijana Tadic et al.   PHARMACOLOGICAL RESEARCH

Angiotensin converting enzyme inhibitors use and development of lung cancer: A systematic review and meta-analysis.

(2019) Waled Bahaj et al.   JOURNAL OF CLINICAL ONCOLOGY

The contamination of valsartan and other sartans, part 1: New findings

(2019) Fritz Sörgel et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis

(2019) Marc A Suchard et al.   LANCET

Evaluating large-scale propensity score performance through real-world and synthetic data experiments

(2018) Yuxi Tian et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study

(2018) Blánaid M Hicks et al.   BMJ-British Medical Journal

The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival

(2017) Taejong Song et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014

(2017) Chanu Rhee et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lowered Cancer Risk With ACE Inhibitors/ARBs: A Population-Based Cohort Study

(2013) Yi-Ying Chiang et al.   Journal of Clinical Hypertension

Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study

(2011) Chia-Hsuin Chang et al.   JOURNAL OF CLINICAL ONCOLOGY

Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

(2010) Ilke Sipahi et al.   LANCET ONCOLOGY

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

(2010) Sripal Bangalore et al.   LANCET ONCOLOGY

Reinventing the ACE inhibitors: some old and new implications of ACE inhibition

(2009) Kashif Hanif et al.   HYPERTENSION RESEARCH